For citations:

Shestakova M.V., Yudovich E.A. Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies. Diabetes mellitus. 2017;20(3):220-230. (In Russ.)